Luis Fong
Psychiatric/Mental Health · Phoenix, AZNPI 1598259467
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $50,600 of the $59,079 with a category attached, or 85.6%. AbbVie accounts for 91.4% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2021 at $22,260 and has fallen 69.2% since, to $6,855 in 2025. Among psychiatric/mental health clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 368 payments — averaging $160.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$54K
- Alkermes, Inc.$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Sunovion Pharmaceuticals Inc.$520
- Otsuka America Pharmaceutical, Inc.$254
- Johnson & Johnson$194
- plus $1K from 15 others
What the payments were for
- Speaking & faculty fees$50,60086%
- Travel & lodging$1,8133%
- Food & beverage$6,57411%
- Education$920%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 160 | $53,972 |
| Alkermes, Inc. | 40 | $1,619 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 72 | $1,432 |
| Sunovion Pharmaceuticals Inc. | 28 | $520 |
| Otsuka America Pharmaceutical, Inc. | 13 | $254 |
| Johnson & Johnson | 6 | $194 |
| Teva Pharmaceuticals USA, Inc. | 8 | $190 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $136 |
| Janssen Scientific Affairs, LLC | 1 | $135 |
| Neurocrine Biosciences, Inc. | 6 | $128 |
| E.r. Squibb & Sons, L.L.C. | 5 | $89 |
| Indivior Inc. | 3 | $84 |
| Sumitomo Pharma America, Inc. | 1 | $78 |
| Supernus Pharmaceuticals, Inc. | 5 | $70 |
| Vanda Pharmaceuticals Inc. | 3 | $51 |
| Tris Pharma Inc | 3 | $50 |
| Lundbeck LLC | 1 | $18 |
| Tempus AI, Inc | 1 | $16 |
| Almatica Pharma LLC | 1 | $16 |
| Corium, LLC | 1 | $14 |
| Lilly USA, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$59,079 in reported general payments places this provider in the 95th percentile of 1,230 psychiatric/mental health providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 52 | $75,669 |
| VyvanseLisdexamfetamine Dimesylate | 12 | $4,490 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 17 | $3,219 |
| Vilazodone Hcl | 13 | $2,917 |
| Buspirone Hcl | 93 | $1,704 |
| Bupropion Hcl SrBupropion Hcl | 58 | $1,439 |
| Quetiapine Fumarate | 43 | $992 |
| Clonazepam | 82 | $966 |
| Mirtazapine | 61 | $855 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 22 | $782 |
| Aripiprazole | 34 | $750 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 12 | $654 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 34 | $614 |
| Duloxetine Hcl | 22 | $589 |
| Bupropion XlBupropion Hcl | 13 | $547 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $53,972 | $75,66952 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse | $136 | $4,49012 claims |
| Lilly USA, LLCOlanzapine | $12 | $29314 claims |
| Almatica Pharma LLCSertraline Hcl | $16 | $19524 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,230 psychiatric/mental health providers in Arizona.
Other psychiatric/mental health in Phoenix
- Elizabeth ElliottPhoenix$363K
- Russell HorningPhoenix$254K
- Claire ReecePhoenix$88K
- Marilizabeth BirkPhoenix$34K
- Jaime LecomtePhoenix$15K
- Roger MayorgaPhoenix$10K
- Elena SassPhoenix$9K
- Martha SerranoPhoenix$8K
- Bonnie VogesPhoenix$7K
- Brandy HammondPhoenix$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.